BKHAR (BKHAR) — Current Report

AI-Powered SEC Filing Analysis

← All BKHAR filings

Want the newest filings?

This analysis covers the filing from 2026-04-01. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-03-17
  • Black Hawk Acquisition Corp has announced the appointment of Michael Tolentino as the new CEO of its proposed business combination target, Vesicor Therapeutics, Inc.
  • The employment agreement with Tolentino provides details on his compensation, termination provisions, and non-compete restrictions, which are important for understanding the leadership transition.
  • Tolentino has a strong background as a serial entrepreneur, retinal surgeon, and biotechnology executive, which could benefit Vesicor's development pipeline and future prospects.
Filed: 2026-02-19
  • Black Hawk Acquisition Corp. issued a $300,000 convertible promissory note to its sponsor, Black Hawk Management LLC, to fund working capital expenses. The note has a 10% annual interest rate and can be converted to ordinary shares of the post-business combination company at $1.00 per share upon completion of the initial business combination.
  • The issuance of the convertible note to the sponsor provides additional financing for the company's operations leading up to the initial business combination, while also allowing the sponsor to convert the debt to equity in the post-combination company.
  • The conversion of the note to ordinary shares upon the initial business combination could result in the sponsor increasing its ownership stake in the post-combination company, which may impact the existing shareholders' equity position.

Other reports for BKHAR

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.